According to two new studies, the latest generation of birth control pills such as Yaz, Yasmin and Ocella pose a higher risk of blood clotting. The studies, published in the British Medical Journal, found that drospirenone, the new progestin component in the contraceptives, carries a two to three times greater risk of blood clots than previous types of birth control pills containing an older progestin ingredient called levonorgestrel. As we have reported previously, there are hundreds of lawsuits pending across the country. Those cases allege that Yaz, Yasmin and Ocella cause blood clots, as well as heart attacks, strokes and gallbladder failure.
Allegations in these cases have been that drospirenone, a diuretic, causes an increase in potassium to unsafe levels, which can disrupt heart rhythms and slow the flow of blood, leading to clotting. Bayer Healthcare Pharmaceuticals is the maker of Yaz/Yasmin. Last spring, the FDA required Bayer to update its ads and promotional materials after the company changed its warning label to include new information about the risk of thromboembolism compared to other contraceptives.
Our firm is handling a number of cases involving Yaz, Yasmin, and Ocella against Bayer. If you need more information contact Roger Smith, a lawyer in our Mass Torts Section, at 800-898-2034 or by email at Roger.Smith@beasleyallen.com.
Source: Lawyers USA Online
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.